Data on Higher Dose of Copaxone and Data Showing Copaxone is Most,Cost Effective ( and allEuropean countries. In North ...)

Data on Higher Dose of Copaxone and Data Showing Copaxone is Most,Cost Effective

, and all European countries. In North America, COPAXONE is marketed by Teva Neuroscience, Inc., which is a subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA). In Europe, COPAXONE is marketed by Teva Pharmaceutical Industries Ltd. and sanofi-aventis. COPAXONE is a registered trademark of Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Close to 90 percent of Teva’s sales are in North America and Europe. Teva’s innovative R&D focuses on developing novel drugs for diseases of the central nervous system.

See additional important information at http://www.copaxone.com/pi/index.html or call 1-800-887-8100 for electronic releases. For hardcopy releases, please see enclosed full prescribing information.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on management’s current beliefs and expectations and involve a number of known and unknown risks and uncertainties that could cause Teva’s future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: Teva`s ability to successfully develop and commercialize additional pharmaceutical products, the introduction of competing generic equivalents, the extent to which
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
2. New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
3. Diabetes Linked to Higher Parkinsons Risk
4. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
5. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
6. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
7. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
8. First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
9. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Ranbaxy ... Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on ... in recent years to address past conduct under ... Daiichi Sankyo continues to support ... the conduct of the past which led to ...

(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...

(Date:5/22/2013)... FRANKLIN LAKES, N.J. , May 22, 2013 /PRNewswire/ ... ), a leading global medical technology company, announced today ... This is BD,s fifth Sustainability Report and it continues ... sustainability. "We believe the principles of ... communities and addressing healthcare challenges of societies — are ...

Breaking Medicine Technology:Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3 BD Issues 2012 Sustainability Report 2 BD Issues 2012 Sustainability Report 3

[0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference [0] BD Issues 2012 Sustainability Report

... efficacy and benefits of early treatment ... with liraglutide versus glimepiride, SAN FRANCISCO, ... of the American Diabetes Association (ADA),demonstrated that once-daily liraglutide when ... in,patients with type 2 diabetes, as compared to glimepiride, a ...

... Calif., June 10 /PRNewswire-FirstCall/ - NeurogesX, Inc.,(Nasdaq: ... and,commercializing novel pain management therapies, announced today the,publication ... candidate, NGX-4010, in the,journal Neurology. The paper, titled, ... Painful HIV,Neuropathy," will appear in the June 10, ...

Cached Medicine Technology:Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 2 Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 3 Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 4 NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2 NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3

Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology

(Date:5/22/2013)... 2013 Zensah® Compression Apparel released a ... titled "Breast pain while running affects one-third ... could help." According to the article, a British study ... amount suffer from breast pain while running but do ... issue. , Zensah emphasizes the importance for women ...

(Date:5/22/2013)... 2013 Successful Therapy for Parents ... Psychotherapy in the Silver Lake community of Los ... as progression to existing Parents and Couples counseling ... parenting therapy has always been suggested, but now ... now specializes in all aspects of relationships ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona State ... intensive startup accelerator designed to help them execute their ... local jobs as part of ASU’s Edson Student ... offers approximately 20 student teams up to $20,000 each ... launch their for-profit, more-than-profit or nonprofit ventures. The program, ...

(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- Migraines ... suffering, but new research indicates the combination of the ... a smaller brain. , , Already aware that people ... wanted to determine if having both conditions together affected ... 2 percent -- isn,t alarming, study authors said, but ...

(Date:5/22/2013)... May 22, 2013 Hurricane preparation isn’t ... home. That’s why Amica Insurance is reminding ... the upcoming hurricane season. , “An important part of ... Cook, a senior assistant vice president at Amica Insurance. ... before the threat of a storm.” , Flood damage ...

[0] Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners [0] Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Having Both Migraines, Depression May Mean Smaller Brain [0] Reviewing Insurance Policies: a Key Part of Hurricane Preparations

... LAS VEGAS, Jan. 8 (LVCC S227) ... a new initiative to make,radio more accessible to ... people around the world., At a press ... Vegas,the three organizations announced the global accessible radio ...

... Slumping Economy &, Presidential Election May Mean for Private Equity in ... ... With credit markets in,turmoil, the economy in a seeming slowdown and ... Equity Analyst Outlook,Conference on January 29-30 at the Grand Hyatt in New ...

... most common indication worldwide for pediatric transplantation, biliary atresia ... disease in newborns. Recently, Childrens Hospital of Pittsburgh of ... with biliary atresia face that lead to the need ... children undergoing their first liver transplant are diagnosed with ...

... population growth since the beginning of the XXth Century, ... slave trade and colonization. The regions population in fact ... in 2005. The latest United Nations projections, published in ... billion inhabitants being reached between the present and 2050., ...

... and improves ... customer ... subsidiary of Hays plc., one of the world,s leading specialist,recruitment ... processes and improve customer service., Hays stated that it ...

... MONTVALE, N.J., Jan. 8 Jennifer J. Day, Senior ... announces the,addition of Kenneth A. Sylvia as publisher of ... the healthcare industry who brings to DHM,30 years of ... client bases we serve," Day said. DHM is a ...

Cached Medicine News:Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 2 Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 3 Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 4 Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 5 Health News:Private Equity's Top Execs to Share Advice, Candid Predictions at 2008 Outlook Conference 2 Health News:Children's Hospital physicians publish review of transplant issues in patients with biliary atresia 2 Health News:Sub-Saharan Africa: the population emergency 2 Health News:Sub-Saharan Africa: the population emergency 3 Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 2 Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 3 Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 4

NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired Private Equity's Top Execs to Share Advice, Candid Predictions at 2008 Outlook Conference Children's Hospital physicians publish review of transplant issues in patients with biliary atresia Sub-Saharan Africa: the population emergency Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing Kenneth A. Sylvia Named as New Publisher of Current Psychiatry

... is suspected, every minute counts. ... allows rapid determination of the ... a single whole blood sample. ... within minutes - saving you ...

... Endoscopic cases it is extremely popular to combine ... Light. This combination affords the surgeon optimal ... an uncomfortable pose. The Dual Light System ... System. As such the light can be ...

... offers all the performance of a major surgical ... use in Outpatient Settings, Minor Procedure Rooms, C-Section, ... single lights either side of the OR table ... General OR when combining Flat Screen LCD Monitors ...

A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....

Medicine Products:

TROPT Sensitive NUVO Surgical Light - Double Light Head Monitor Ready NUVO Surgical Light - Single Light Head Anti-Myelin Associated Glycoproteins (MAG) Western Blot